Calcium deposit in bursa

M13_CALCBURS

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	519972
1. Apply sex-specific rule None	519972
2. Check conditions None	519972
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — M71.4 Cause of death: ICD-10 — M71.4 2 out of 7 registries used, show all original rules.	76
4. Check minimum number of events None	76
5. Include endpoints None	76
6. Filter based on genotype QC (FinnGen only)	76

Control definitions (FinnGen only)

Control exclude: M13_SOFTTISSUE

Extra metadata

Level in the ICD hierarchy: 4
First used in FinnGen datafreeze: DF2
Parent code in ICD-10: M71
Name in latin: Calcificatio bursae

NAME	M13_CALCBURS
CONTROL_EXCLUDE	M13_SOFTTISSUE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	M714
HD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	M714
COD_ICD_9	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_8	$!$	The FinnGen clinical team has checked and no code can be used for this rule.
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Calcium deposit in bursa based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	441	216	224
Only index persons	420	209	211
Unadjusted period prevalence (%)
Whole population	0.01	0.01	0.01
Only index persons	0.01	0.01	0.01
Median age at first event (years)
Whole population	54.38	54.77	53.91
Only index persons	53.77	54.21	53.33

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	76	41	35
Unadjusted period prevalence (%)	0.02	0.01	0.02
Median age at first event (years)	52.50	49.93	55.50

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

No data

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
76: Matched controls
760

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

M71.4

ICD-10 Finland

Calcium deposit in bursa

+∞

109.3

NCM20

NOMESCO Finland

Excision of synovial ganglion of elbow or forearm

+∞

11.8

NBG10

NOMESCO Finland

Acromioplastia

113.6

9.7

M75.1

ICD-10 Finland

Rotator cuff syndrome

4.7

7.7

NHM20

NOMESCO Finland

Excision of synovial ganglion of ankle or foot

44.2

6.9

M79.6

ICD-10 Finland

Pain in limb

3.5

6.8

154

M75.4

ICD-10 Finland

Impingement syndrome of shoulder

20.1

6.4

J01DB01

ATC

cefalexin; oral

5.8

6.1

508

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

137

2.97

4.78

4.9

4.4

—

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

7.12

2.92

1.3

1.2

—

(3019060) Gas panel - Arterial blood

3.28

2.77

4.3

3.7

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

223

2.17

2.73

2.0

1.6

92.07

94.77

pmol/l

0.15

115

(3019198) Lymphocytes [#/volume] in Blood

278

2.14

2.67

8.4

5.0

1.84

1.78

e9/l

0.18

254

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

7.54

2.59

1.2

2.1

—

(3006315) Basophils [#/volume] in Blood

272

2.10

2.56

7.6

5.1

0.05

0.04

e9/l

2.13

238

(40768804) Tissue Pathology biopsy report

254

2.10

2.56

1.8

2.1

—

(3007853) Bacteria identified in Skin by Aerobe culture

2.73

2.54

2.0

1.6

—

(3001604) Monocytes [#/volume] in Blood

271

2.00

2.28

7.1

5.1

0.62

0.58

e9/l

0.38

237

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

5.85

2.25

1.0

2.3

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

5.85

2.25

1.0

2.3

—

(3023024) Carbon dioxide [Partial pressure] in Capillary blood

3.26

2.23

4.2

2.7

5.57

5.19

kpa

—

(3042936) Bacteria identified in Isolate by Culture

2.37

2.15

2.0

1.5

—

(3022313) Gas panel - Capillary blood

3.74

2.11

3.6

2.5

—

(3007566) Smooth muscle Ab [Titer] in Serum

5.26

2.10

1.4

1.3

—

(40768797) Stomach Pathology biopsy report

2.33

2.09

1.3

1.2

—

(3019225) pH of Specimen

2.69

2.03

11.5

4.1

—

(3013115) Eosinophils [#/volume] in Blood

281

1.89

1.97

8.4

5.4

0.21

0.17

e9/l

0.87

252

(3042111) Morphology [Interpretation] in Bone marrow Narrative

4.78

1.97

1.2

1.6

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

134

2.03

1.95

3.6

2.0

—

(3017732) Neutrophils [#/volume] in Blood

3.07

1.92

9.0

2.0

4.62

6.20

e9/l

—

(40760892) CBC W Ordered Manual Differential panel - Blood

247

1.87

1.89

10.1

6.1

—

(3009445) Proteinase 3 Ab [Units/volume] in Serum

3.74

1.87

1.2

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

3.74

1.87

1.2

2.0

—

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

3.24

1.85

2.1

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

188

1.88

1.79

2.9

1.9

60.62

82.75

u/l

0.38

173

(3015235) Bicarbonate [Moles/volume] in Capillary blood

4.04

1.74

3.2

2.7

27.26

26.78

mmol/l

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

2.21

1.60

3.6

2.3

18.34

21.40

0.45

(3022217) INR in Platelet poor plasma by Coagulation assay

268

1.74

1.55

21.4

13.4

1.44

1.29

inr

0.39

(3044640) Blood type and Crossmatch panel - Blood

187

1.79

1.54

3.6

2.0

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

2.30

1.53

2.9

1.9

117.45

137.98

ng/l

0.15

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

272

1.70

1.44

3.9

2.3

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

330

1.70

1.42

9.4

11.2

4.46

4.21

e9/l

0.20

291

(3026008) Bacteria identified in Urine by Culture

165

1.77

1.42

2.3

2.6

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

2.74

1.39

2.0

1.9

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

3.07

1.38

1.2

2.0

—

(4094501) Cardiovascular stress test using bicycle ergometer

2.60

1.17

1.0

1.1

—

(40768443) Skin Pathology biopsy report

2.46

1.16

1.0

1.1

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

2.38

1.14

9.7

7.1

—

(3009508) Creatinine [Moles/volume] in Urine

184

1.63

1.12

2.4

2.9

6.95

7.48

mmol/l

0.26

151

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

2.06

1.12

2.6

2.2

1.78

1.30

—

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

161

1.61

1.03

3.0

2.5

3243.56

1094.02

ng/l

0.34

143

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

1.74

1.00

2.2

1.8

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

631

2.01

0.99

5.0

4.4

4.61

4.69

mmol/l

0.25

593

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

453

1.56

0.96

3.5

3.6

14.51

14.96

pmol/l

0.63

403

(3012516) Albumin [Mass/volume] in Urine

173

1.57

0.95

2.2

3.1

89.43

90.38

mg/l

0.00

112

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

2.16

0.91

8.8

5.3

25.18

25.47

mmol/l

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

610

1.83

0.91

4.4

3.9

1.23

1.26

mmol/l

0.16

566

(3036481) Cortisol [Moles/volume] in Serum or Plasma

1.91

0.89

1.6

1.4

459.00

369.89

nmol/l

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

288

1.48

0.87

11.7

6.7

1.21

1.22

mmol/l

0.41

252

(3002032) Base excess in Venous blood by calculation

1.82

0.85

5.5

3.6

1.46

2.82

mmol/l

—

(3004119) Hemoglobin [Mass/volume] in Venous blood

1.95

0.83

5.2

3.4

99.33

131.94

g/l

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

628

1.79

0.83

4.9

4.3

1.46

1.50

mmol/l

0.23

582

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

619

1.69

0.79

25.5

12.2

32.79

23.34

mg/l

0.94

472

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.16

0.76

2.6

1.7

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

641

1.83

0.75

5.6

4.9

2.70

2.77

mmol/l

0.26

598

(3000991) Gas panel - Venous blood

1.69

0.69

9.1

5.9

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

347

1.39

0.68

3.8

3.0

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

1.84

0.67

3.2

2.3

—

(3013512) EKG study

168

1.44

0.65

6.4

3.7

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

320

1.38

0.64

8.8

6.2

9.96

10.68

umol/l

0.29

304

(3020682) Albumin/Creatinine [Ratio] in Urine

187

1.41

0.64

3.1

3.7

12.28

15.21

mg/mmol

0.09

114

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

401

1.37

0.62

4.9

2.6

71.09

49.49

u/l

0.50

373

(4034850) Laboratory test

0.00

0.61

0.0

11.0

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

1.52

0.57

1.8

1.5

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

230

1.34

0.53

4.2

3.3

27.58

37.86

ng/l

0.43

157

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

239

0.73

0.52

5.2

3.5

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

203

1.35

0.51

5.1

2.6

40.52

29.67

u/l

1.36

196

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

1.51

0.45

4.3

3.2

—

(3041096) Erythrocytes [Presence] in Urine by Automated

181

0.72

0.45

5.2

3.3

—

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

1.65

0.44

8.0

6.3

0.58

0.73

—

(3022621) pH of Urine by Test strip

1.65

0.44

5.4

2.4

—

(3000850) Epithelial cells [#/volume] in Urine

124

1.37

0.43

2.4

2.5

1.43

6.07

e6/l

4.77

108

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

1.60

0.43

8.0

6.2

1.94

1.82

—

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

0.00

0.41

0.0

4.2

—

35.14

—

(1002224) Polysomnography panel

0.00

0.41

0.0

1.2

—

(3034860) Kappa light chains.free [Mass/volume] in Serum

0.00

0.41

0.0

4.2

—

52.37

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

648

1.47

0.41

26.4

13.6

3.99

3.96

mmol/l

0.30

628

(3019550) Sodium [Moles/volume] in Serum or Plasma

646

1.50

0.41

26.1

13.5

139.41

139.90

mmol/l

0.96

626

(3000494) Fungus identified in Specimen by Culture

1.37

0.39

1.9

1.5

—

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

0.00

0.39

0.0

1.1

—

(3022145) Colonoscopy Study observation

1.34

0.39

1.1

1.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

1.34

0.39

5.4

6.5

104.67

104.68

mmol/l

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

1.46

0.36

2.0

1.5

—

(3000492) Spirometry study

1.30

0.31

1.3

1.6

—

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

1.30

0.29

2.1

1.6

—

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

1.28

0.28

2.1

1.7

—

(3037467) Urinalysis macro (dipstick) panel - Urine

416

1.20

0.28

6.2

3.7

—

(3011397) Hemoglobin [Presence] in Urine by Test strip

124

1.26

0.26

2.4

2.9

—

(3044889) 12 lead EKG panel

449

1.19

0.24

4.0

3.8

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

670

1.32

0.24

15.7

9.7

25.57

25.90

u/l

0.07

642

(3020564) Creatinine [Moles/volume] in Serum or Plasma

667

1.37

0.24

26.1

14.6

86.06

77.63

umol/l

0.35

667

(40761511) CBC panel - Blood by Automated count

656

1.35

0.23

20.4

12.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

108

1.25

0.22

2.2

1.8

—

(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.5

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

2.0

—

257.70

—

(40760888) Immunoglobulin light chains.free panel - Serum

0.00

0.21

0.0

5.7

—

(3039443) Prostate specific Ag panel - Serum or Plasma

0.00

0.21

0.0

1.6

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

0.00

0.21

0.0

3.5

—

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

0.00

0.21

0.0

1.9

—

5.20

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.00

0.21

0.0

1.6

—

(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis

0.00

0.21

0.0

1.1

—

(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay

0.00

0.21

0.0

1.1

—

1.00

—

(3024891) Influenza virus A+B Ag [Presence] in Specimen

0.00

0.21

0.0

1.0

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.0

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

0.00

0.21

0.0

1.0

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

483

1.17

0.20

11.6

7.0

79.71

78.17

u/l

0.14

450

(3021879) Hepatitis B virus core Ab [Presence] in Serum

1.24

0.20

1.0

1.3

—

(1761868) Lipid panel - Serum or Plasma

236

0.85

0.20

2.1

3.0

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

0.00

0.20

0.0

2.2

—

180.20

—

(3006588) Cancer Ag 15-3 [Units/volume] in Serum or Plasma

0.00

0.20

0.0

3.6

—

71.64

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

1.16

0.18

1.3

1.7

—

(3002256) Pathology report gross observation

1.17

0.16

1.4

1.2

—

(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count

210

0.87

0.14

3.4

2.7

—

(36304419) Bacteria [Presence] in Urine

166

0.88

0.11

3.0

2.4

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

1.12

0.09

1.0

1.3

—

(3024731) MCV [Entitic volume]

699

1.24

0.08

34.1

18.5

91.50

91.14

0.25

686

(3019832) Treponema pallidum Ab [Presence] in Serum

0.81

0.08

1.2

1.7

—

(3010813) Leukocytes [#/volume] in Blood

700

1.22

0.08

34.4

18.7

7.01

6.51

e9/l

0.93

680

(3026361) Erythrocytes [#/volume] in Blood

700

1.22

0.08

34.3

18.5

4.45

4.50

e12/l

0.33

680

(3000963) Hemoglobin [Mass/volume] in Blood

700

1.22

0.08

34.4

18.7

132.82

135.63

g/l

0.82

686

(3035941) MCH [Entitic mass]

700

1.22

0.08

34.1

18.4

30.31

30.34

0.05

687

(3007461) Platelets [#/volume] in Blood

698

1.26

0.08

34.6

18.6

251.04

247.00

e9/l

0.18

681

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

0.77

0.08

5.2

7.8

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

1.07

0.08

2.3

1.5

—

(21494755) Public health laboratory ask at order entry panel

0.82

0.08

1.7

1.4

—

(3003694) ABO and Rh group [Type] in Blood

173

0.90

0.07

2.1

1.4

—

(40758558) Short blood count panel - Blood

151

0.91

0.06

3.9

7.8

—

(3021589) Normoblasts [#/volume] in Blood

272

1.05

0.02

8.9

11.6

0.01

e9/l

0.12

223

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

114

1.06

0.01

1.4

—

(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)

604

1.05

0.00

20.0

11.6

78.84

81.23

ml/min/173m2

0.36

490

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

184

1.04

0.00

5.0

4.2

25.25

22.58

—

(3018095) Leukocytes [#/volume] in Urine

226

0.96

0.00

4.1

3.1

74.31

73.86

e6/l

0.00

156

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

221

0.99

0.00

5.4

4.8

1.28

3.37

ug/l

0.81

195

(3015736) pH of Urine

246

1.02

0.00

3.6

2.9

—

5.78

—

(3003434) Protein [Mass/volume] in Pleural fluid

0.00

0.0

1.3

—

33.44

—

(4281824) Cell count and differential, peritoneal fluid

0.00

0.0

1.0

—

(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction

0.00

0.0

1.1

—

184.39

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

0.00

0.0

1.0

—

256.57

—

(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH

0.00

-0.00

0.0

1.0

—

(3020044) Glucose [Moles/volume] in Cerebral spinal fluid

0.00

-0.00

0.0

1.3

—

3.66

—

(1617658) Protocol used for examination of sentinel lymph nodes

0.00

-0.00

0.0

1.0

—

(3002523) Influenza virus A Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.00

-0.00

0.0

1.0

—

(3028707) Methadone [Presence] in Urine by Screen method

0.00

-0.00

0.0

1.3

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

0.00

-0.00

0.0

7.6

—

(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.1

—

18.04

—

(3046294) Neutrophil cytoplasmic Ab.classic [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.4

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

0.00

-0.00

0.0

1.2

—

(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal

0.00

-0.00

0.0

1.2

—

7.75

—

(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid

0.00

-0.00

0.0

1.2

—

10.67

—

(3044290) Cell count panel - Cerebral spinal fluid

0.00

-0.00

0.0

2.1

—

(4035726) Immunohistochemistry procedure

0.92

-0.00

1.0

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

0.00

-0.00

0.0

1.0

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

0.00

-0.00

0.0

1.4

—

954.60

—

(3000081) cloZAPine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

19.8

—

1809.00

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

0.00

-0.00

0.0

3.3

—

(3036782) Glucose [Moles/volume] in Pleural fluid

0.00

-0.00

0.0

1.3

—

5.68

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

0.00

-0.00

0.0

1.2

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

4.0

—

3.58

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.6

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

0.87

-0.00

1.2

1.6

—

(3008832) Norclozapine [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

12.2

—

974.17

—

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

3.3

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

15.20

—

(3025130) Human papilloma virus identified in Specimen

0.00

-0.00

0.0

2.1

—

(21494434) Karyotype in Bone marrow

0.00

-0.00

0.0

1.0

—

(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum

0.00

-0.00

0.0

1.0

—

(3015183) Erythrocyte sedimentation rate

0.00

-0.00

0.0

1.0

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

0.99

-0.00

1.2

1.4

—

(40768806) Pleura Pathology biopsy report

0.00

-0.00

0.0

2.2

—

(40768441) Liver Pathology biopsy report

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint M13_CALCBURS and mortality.

Females

No data

Males

No data

Mortality risk

Mortality risk for people of age

years, who have M13_CALCBURS.

N-year risk	Females	Males
1	No data	No data
5	No data	No data
10	No data	No data
15	No data	No data
20	No data	No data

Relationships between endpoints

↥

Index endpoint: M13_CALCBURS – Calcium deposit in bursa

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Calcium deposit in bursa

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints